> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA, FTC Advancing Biologic Competition
- URL: https://www.fdaweb.com/fda-ftc-advancing-biologic-competition/
- Published: 2023-03-02T12:00:00.000Z
- Updated: 2026-09-14T18:17:55.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5153888

CDER director **Patrizia Cavazzoni** says FDA and the Federal Trade Commission (FTC) are working together to help advance competition for biologics, including biosimilars and interchangeable biosimilars. Writing in an online *FDA Voices* [post](https://www.fda.gov/news-events/fda-voices/fda-and-ftc-collaborate-advance-competition-biologic-marketplace?ref=fdaweb.com), Cavazzoni says the agencies’ commitments were detailed in a 2/3/2020 [joint statement](http://www.fda.gov/media/134864/download?ref=fdaweb.com). That was followed by a 3/2020 joint public workshop at which participants from industry, academia, and government agencies discussed competition in the biologics market. A [summary report](https://www.fdaweb.com/fda-ftc-biosimilar-workshop-summary-out/) on that workshop was recently released.

“Since the workshop,” Cavazzoni says, “the agencies have worked together on issues such as exchanging information about how to combat activities that undermine competition and/or harm the public health. FDA and FTC share concerns about false or misleading information and their negative impacts on public health and drug companies.”

Cavazzoni says the two agencies have developed an [educational resource](http://www.fda.gov/media/165656/download?ref=fdaweb.com) for consumers about biosimilars and interchangeable biosimilars to help address common misperceptions. “Unwarranted concerns may discourage patients and their healthcare providers from using or switching to a biosimilar,” Cavazzoni says, “so it is important to know the facts. Unbiased information can help patients and their providers understand the treatment options available.”